United States — Startups · corporate
Issued Shares Without Board Approval Startup: How to Fix in the United States
In the United States, equity issued without formal board approval constitutes a defective corporate act that renders the stock putative or voidable under corporate law. This procedural defect can paralyze upcoming funding rounds, M&A exits, and investor due diligence if left unresolved. Fortunately, statutory self-help frameworks like Delaware General Corporation Law (DGCL) Section 204 allow startups to formally ratify unauthorized share issuances retroactively without court intervention.
This guide covers everyone. Your situation is yours.
The rules are the same for everybody, but what you should do depends on your dates, your documents, and what the other side has said. On Caunsel you write down what's actually going on and get answers about your situation, with the law they rely on, or just talk it through out loud. If it needs follow-up, you keep it as a case, and when there's paperwork, it'll suggest what you need, write it up, and you can e-sign it right there.
You've read a few of these by now.
None of them were about you. That's how generic guides work. They have to cover everybody. On Caunsel you write down what's actually going on and get answers about your situation, or just talk it through out loud. If it needs follow-up, you keep it as a case, and when there's paperwork, it'll suggest what you need, write it up, and you can e-sign it right there.
What the law says about unauthorized stock in United States startups
In the United States, corporate governance for venture-backed startups is predominantly governed by the state of incorporation, most frequently Delaware under the Delaware General Corporation Law (DGCL). Under 8 Del. C. § 152 and § 153, the authority to issue capital stock and determine the consideration for those shares belongs exclusively to the board of directors. Officers, including the Chief Executive Officer, have no inherent legal authority to issue shares, grant options, or promise equity to co-founders, employees, or advisors without a duly adopted board resolution or unanimous written consent under 8 Del. C. § 141(f).
Historically, Delaware common law treated stock issued without statutory authority or board authorization as void ab initio—incapable of retroactive cure under cases like Waggoner v. Laster. In 2014, Delaware modernized this doctrine by enacting 8 Del. C. § 204 and § 205. Section 204 establishes a statutory self-help mechanism to ratify 'defective corporate acts' and validate 'putative stock' (shares that would have been valid but for a failure of authorization). Other states following the Model Business Corporation Act (MBCA §§ 1.45–1.52) have enacted comparable ratification provisions. If statutory ratification fails or the cap table is disputed, 8 Del. C. § 205 allows an interested party to petition the Delaware Court of Chancery to determine the validity of the stock.
How to execute a Section 204 statutory ratification
A proper DGCL § 204 cleanup requires strict adherence to statutory mechanics; taking casual shortcuts will not cure the underlying defect. The current, valid board of directors must formally adopt resolutions that satisfy 8 Del. C. § 204(b)(1). The resolutions must identify: (1) the specific defective corporate act to be ratified; (2) the date the act purportedly occurred; (3) the number and class of putative shares issued and their purported issuance dates; (4) the exact nature of the failure of authorization; and (5) an express statement that the board approves the ratification.
Once the board adopts these resolutions, determine whether stockholder approval is mandatory. Under § 204(c), stockholder approval is required if the underlying issuance required a stockholder vote either when the shares were purportedly issued or at the time of ratification (such as an issuance that exceeded the company's authorized share count and required a certificate amendment). If stockholder approval is required, § 204(d) mandates giving at least 20 days' advance notice to all holders of valid and putative stock. Even if stockholder approval is not required, § 204(g) mandates prompt post-adoption notice to all stockholders. Finally, if the original act required a filing with the Secretary of State, the startup must file a Certificate of Validation under § 204(e).
What you can do next to protect your startup
Do not allow panic to push you into fraudulent fixes. The single most dangerous trap for founders facing imminent due diligence is backdating board consents. Backdating documents constitutes misrepresentation, exposes directors to breach of fiduciary duty claims, and triggers severe scrutiny from prospective investors' counsel. Institutional investors understand that early-stage corporate governance contains errors; they routinely expect Section 204 cleanups, but they will walk away if they uncover falsified records.
Perform an immediate cap table audit against your historical minute book to isolate all putative shares, grant notices, and vesting agreements. Document whether the shares fit within your Certificate of Incorporation's authorized capital at the time of issuance. You can use Caunsel to research your jurisdiction's corporate requirements, organize your capitalization documents within a secure case, or connect directly with an independent corporate attorney to draft statutory ratification resolutions.
Steps
- Audit your cap table and board consents: Compare every signed stock purchase agreement and option grant against your formal board meeting minutes and unanimous written consents to identify every putative share and the exact date of defective issuance.
- Check your authorized share count: Review your Certificate of Incorporation filed with your state of incorporation as of the purported issuance date to confirm whether the company had sufficient authorized unissued shares to accommodate the grant.
- Draft Section 204 board resolutions: Prepare board resolutions that precisely satisfy 8 Del. C. § 204(b), detailing the defective act, putative share count, nature of the authorization failure, and formal board approval.
- Evaluate stockholder voting and notice mandates: Determine if a stockholder vote is required under § 204(c); provide formal statutory notice to all holders of valid and putative stock pursuant to § 204(d) or § 204(g).
- File a Certificate of Validation if necessary: If the defective issuance required a charter amendment (e.g., increasing authorized stock), file a Certificate of Validation with the Delaware Division of Corporations pursuant to § 204(e).
These are the general steps. Caunsel works out which ones apply to you, with your dates and documents.
Get help for my businessCommon mistakes
- Backdating board consents or signature dates to make it appear that the board authorized the shares before they were issued.
- Failing to notify putative stockholders: DGCL § 204 requires statutory notice to both valid and putative stockholders; omitting putative holders invalidates the ratification.
- Allowing putative shares to vote on their own ratification when stockholder approval is required, distorting corporate quorum and voting thresholds.
- Assuming an informal email from a director or an officer signature on a stock purchase agreement substitutes for a formal board resolution.
Questions people ask
Are shares issued without board approval completely void or can they be fixed?
Under modern Delaware law (8 Del. C. § 204), shares issued without board approval are classified as 'putative stock' resulting from a defective corporate act. While historically treated as void, they are now voidable and can be retroactively cured into valid stock by completing the statutory ratification process or seeking validation under § 205.
Does ratifying unauthorized shares always require a shareholder vote?
No. Under DGCL § 204(c), stockholder approval is only required if the act being ratified required a stockholder vote at the time it occurred, or if it would require a stockholder vote at the time of ratification. A routine stock issuance within your authorized share limit only requires board approval, meaning the board can ratify it alone, followed by mandatory statutory notice to stockholders.
What happens if our cap table mistake is discovered during venture capital due diligence?
Institutional investors routinely identify unapproved share issuances during legal due diligence. The deal will pause while company counsel drafts and executes a DGCL § 204 ratification as a condition precedent to closing. Being transparent and proactive about executing the cure prevents financing delays and avoids valuation penalties.
Ask Caunsel's AI advisor to review your capitalization timeline, organize your missing consent records, or connect with an independent startup attorney to draft your Section 204 ratification.
Research it with the advisor, keep documents in a case, or talk to an independent lawyer. Start a subscription for AI tools.
General information only, last updated 2026-11-17. Caunsel is not a law firm and does not practise law. AI answers and this guide are not legal advice. Verify filings, deadlines, and statutes with a licensed lawyer in United States — Startups.